XETRA - Delayed Quote EUR

Bayer Aktiengesellschaft (BAYN.DE)

26.33 +0.09 (+0.32%)
At close: April 19 at 5:37 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
47,637,000.00
47,637,000.00
50,739,000.00
44,081,000.00
41,400,000.00
Cost of Revenue
19,749,000.00
19,749,000.00
19,871,000.00
16,816,000.00
19,138,000.00
Gross Profit
27,888,000.00
27,888,000.00
30,868,000.00
27,265,000.00
22,262,000.00
Operating Expense
19,852,000.00
19,852,000.00
23,535,000.00
20,356,000.00
22,976,000.00
Operating Income
8,036,000.00
8,036,000.00
7,333,000.00
6,909,000.00
-714,000.00
Net Non Operating Interest Income Expense
-1,611,000.00
-1,611,000.00
-1,823,000.00
-945,000.00
-1,271,000.00
Pretax Income
-1,621,000.00
-1,621,000.00
4,670,000.00
2,046,000.00
-17,250,000.00
Tax Provision
1,321,000.00
1,321,000.00
504,000.00
1,024,000.00
-1,689,000.00
Net Income Common Stockholders
-2,941,000.00
-2,941,000.00
4,150,000.00
1,000,000.00
-10,495,000.00
Diluted NI Available to Com Stockholders
-2,941,000.00
-2,941,000.00
4,150,000.00
1,000,000.00
-10,495,000.00
Basic EPS
-2.99
-2.99
4.22
1.02
-10.68
Diluted EPS
-2.99
-2.99
4.22
1.02
-10.68
Basic Average Shares
982,420.00
982,420.00
982,420.00
982,420.00
982,420.00
Diluted Average Shares
982,420.00
982,420.00
982,420.00
982,420.00
982,420.00
Total Expenses
39,601,000.00
39,601,000.00
43,406,000.00
37,172,000.00
42,114,000.00
Net Income from Continuing & Discontinued Operation
-2,941,000.00
-2,941,000.00
4,150,000.00
1,000,000.00
-10,495,000.00
Normalized Income
10,068,750.00
10,068,750.00
5,304,132.00
3,507,400.00
156,606.00
Interest Income
484,000.00
484,000.00
379,000.00
346,000.00
202,000.00
Interest Expense
2,047,000.00
2,047,000.00
1,857,000.00
1,347,000.00
1,596,000.00
Net Interest Income
-1,611,000.00
-1,611,000.00
-1,823,000.00
-945,000.00
-1,271,000.00
EBIT
426,000.00
426,000.00
6,527,000.00
3,393,000.00
-15,654,000.00
EBITDA
10,446,000.00
10,446,000.00
13,030,000.00
6,449,000.00
-2,395,000.00
Reconciled Cost of Revenue
19,749,000.00
19,749,000.00
19,871,000.00
16,816,000.00
19,138,000.00
Reconciled Depreciation
10,020,000.00
10,020,000.00
6,503,000.00
3,056,000.00
13,259,000.00
Net Income from Continuing Operation Net Minority Interest
-2,941,000.00
-2,941,000.00
4,150,000.00
1,000,000.00
-15,569,000.00
Total Unusual Items Excluding Goodwill
-7,435,000.00
-7,435,000.00
-471,000.00
-3,582,000.00
-14,953,000.00
Total Unusual Items
-745,000.00
-745,000.00
263,000.00
-3,582,000.00
-12,715,000.00
Normalized EBITDA
11,191,000.00
11,191,000.00
12,767,000.00
10,031,000.00
10,320,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-1,115,250.00
-1,115,250.00
-50,868.00
-1,074,600.00
-1,465,394.00
12/31/2020 - 12/16/1996
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

ROG.SW Roche Holding AG
222.10
+0.95%
 
SAN.PA Sanofi
86.89
+1.95%
 
GRF.MC Grifols, S.A.
8.35
-3.16%
 
PFE Pfizer Inc.
26.00
+2.40%
 
BMY Bristol-Myers Squibb Company
48.93
+1.30%
 
BIIB Biogen Inc.
194.38
+2.03%
 
SNY Sanofi
46.30
+2.00%
 
NOVN.SW Novartis AG
85.53
+1.19%
 
GSK.L GSK plc
1,599.00
+0.98%
 
GSK GSK plc
39.75
+1.22%